Physician profile
Purnima Sau
NPI 1912905266
$863.56
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $75.46 · 2021: $355 · 2022: $179.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $134.20 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $110.74 | 2019-2021 | |
| Leo Pharma INC. | $107.22 | 2019-2021 | |
| Abbvie INC. | $97.96 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $86.31 | 2020-2022 | |
| Genzyme Corporation | $68.41 | 2019-2021 | |
| Galderma Laboratories, L.P. | $57.49 | 2020-2022 | |
| Lilly USA, LLC | $38.22 | 2022 | |
| Sebela Pharmaceuticals INC. | $30.59 | 2019-2021 | |
| Kyowa Kirin, INC. | $28.89 | 2021 | |
| Mayne Pharma Commercial LLC | $27.19 | 2019 | |
| Almirall LLC | $19.77 | 2021 | |
| Incyte Corporation | $19.76 | 2021 | |
| Amgen INC. | $12.91 | 2022 | |
| Merck Sharp & Dohme LLC | $11.97 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $11.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Purnima Sau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.